GlobeNewswire

PRESS RELEASE: BIGBEN: Cumulative 9 month Sales 2020/21: 223.1 M€ (+ 5%)

Share

                                                                                                              Press release

        Lesquin, 25 January 2021 17:45hrs

Cumulative 9 month Sales 2020/21: 223.1 M€ (+ 5%)

Q3 Sales showing growth hallmarked by:

·the further momentum of Nacon Gaming

                  ·The limited impact of the 2 nd lockdown in Audio/Telco

IFRS – M€

Sales


2020/2021


2019/2020


Change


1st Quarter (April, May, June)

Nacon Gaming

Bigben Audio / Telco


55.2

38.0

17.2



58.6

30.5

28.1


- 5.8%

+ 24.5%

- 38.7%
2nd Quarter (July, Aug., Sept.)

Nacon Gaming

Bigben Audio / Telco
80.6

48.6

32.0
68.5

33.2

35,3
+ 17.7%

+ 46.4%

- 9.4%
3rd Quarter (October, Nov., Dec.) (1)

Nacon Gaming

Bigben Audio / Telco
87.3

48.6

38.7
85.4

40.5

44.9
+ 2.3%

+ 20.3%

- 13.9%
Cumulative 9 month (Apr-Dec 2020)

Nacon Gaming

Bigben Audio / Telco
223.1

135.3

87.8
212.4

104.2

108.2
+ 5.0%

+ 29.9%

- 18.9%


(1)  Non audited data

Sales up 2.3% in Q3 2020/21

In Q3 2020/2021 (from October 1 to December 31, 2020), Bigben posted 87.3 M€ sales up 2.3%, driven by the momentum of Nacon Gaming, while the recovery of Audio/Telco was slowed down by the 2nd lockdown.

NACON GAMING 

  • Games : Due to Q3 publishing releases limited to two new games targetting profitable but narrow niches (Monster Truck®, Handball 21), sales were down by 19.7%. The share of digital sales continues to grow and represents 74.4% of quarterly sales. The contribution of the back catalogue(2), a source of high margins, is up very sharply to 6.9 M€ (+ 216% compared to Q3 2019/20).
  • Accessories : Accessories continued their strong growth with 32.5 M€ sales up 58.7%, thanks to the growing success of RIG® headsets and sustained sales of Nacon accessories, particularly of licensed controllers and headsets.

BIGBEN AUDIO/TELCO

Sales in Q3 2020/21 dropped by 13.9% to 38.7 M€. Business was impacted by a second lockdown in autumn 2020, which saw the closure of Audio shelfspaces and a drop of store traffic in Telco shops.  On the other hand, margins recovered with the Audio/Telco product mix being more favourable to the Group's premium brands.

  • Mobile: Over the period, sales of mobile accessories fell by 14.8% to 26.0 M€. The significant increase in sales of the Force, Just Green® and Bigben® ranges, combined with the release of four new iPhone 12’s and the successful launch of TWS wireless headphones, helped to cushion the impact of the market.
  • Audio: In the third quarter, the Audio ranges recorded an overall drop in sales of 12.7% to 12.6 M€. Listings in 600 points of sale in the new "trendy" decoration and wellness channels, as well as the recurring success of Lumin'Us and Bigben Party products, partly offset the decline in this business.

Cumulative 9-month sales up by 5%

Over the first nine months of the 2020/21 financial year (1 April to 31 December 2020), Bigben's sales amounted to 223.1 M€, an increase of 5.0% compared to the first nine months of the previous year. This rise was driven by the strong growth of Nacon Gaming, while the Bigben Audio/Telco business showed its resilience in the current health context.

CSR challenge

The CSR(3) commitment remains a significant challenge for the Bigben Group, which has been moving towards more socially responsible management for several years now. Thus, a teleworking agreement was signed in the summer of 2020 in the Group's main companies, the eco-designed Just Green® range combines ecology with economy, while all the Group's own Audio/Telco ranges and the new Gaming accessory ranges now have "zero plastic" packaging. The Group intends to continue its efforts in this area.

Favourable outlook

Bigben anticipates a more dynamic Q4 2020/21 supported by strong growth at Nacon Gaming. The Group also intends to continue the commercial relaunch of Audio/Telco, which remains sensitive to the impact of the health crisis in the retail sector.

NACON GAMING 

Nacon is again anticipating growth in Q4 2020/21 thanks to:

  • the highly anticipated release of Werewolf® : the Apocalypse - Earthblood, and the release of PlayStation®5 / Xbox Series X|S versions of Monster Truck®, Tennis World Tour®2 and Hunting Simulator® 2 ;
  • contributions from digital sales and the back catalogue(2);
  • the order book for RIG® headphones, which remains high;
  • the release of the first accessories dedicated to the new Xbox Series X|S console.

At the same time, the release of Blood Bowl® III, the first game in the catalogue to feature the live ops(4) model, has been postponed to the first half of 2021/22 in order to optimise its quality, satisfy this franchise’s large community and maximise the title's commercial potential. Despite this postponement, Nacon is confident that it will achieve its annual targets(5).

Nacon has also just announced the signature of an exclusive agreement for the acquisition in full of its 10th studio, the Australian company Big Ant, an expert developer of individual and team sports games (tennis, rugby, cricket, etc.). This transaction considerably strengthens this mainstay of Nacon's portfolio by giving it exclusive access to Big Ant's productions in this strategic segment.

BIGBEN AUDIO/TELCO

In a context of low visibility, Audio/Telco presents a good outlook for its Q4 2020/21 sales after an encouraging start at the beginning of 2021:

  • Mobile: the release of 3 new Galaxy Samsung S21 phones a month earlier than expected and the removal of the original chargers for the latest premium smartphones should have a positive effect on sales of the Bigben® Energy, Force Power® and Just Green® accessory ranges. Sales of TWS Bigben® wireless headphones should continue to grow. The arrival of 5G networks will create a new wave of demand for premium equipment as from the next financial year 2021/22.
  • Audio: During the last FY 2020/21 quarter, Bigben will increase the presence of the Thomson® range in retail outlets and will continue to deliver its "decoration and well-being" products to the 600 points of sale recently referenced.

Annual targets and BIGBEN 2023 Plan confirmed

The Group reiterates its 2020/21 sales target of between 270 M€ and 290 M€, with a current operating margin(6) exceeding 12%, driven by Nacon Gaming publishing and a higher value-added product mix in Audio/Telco.

The Group also reiterates the financial targets of its BIGBEN 2023 strategic plan, with sales of 350 M€ for the 2022/23 financial year and a current operating margin(6) of 13%, the latest could be revised upwards when the annual results are published on 31 May 2021.

As approved at the Ordinary General Meeting on December 11, 2020 by Bigben Interactive Shareholders, Bigben Interactive continues to explore conditions for the issuance of bonds, which could be exchanged for existing shares of a subsidiary of Bigben Interactive. The timing of any transaction would be subject to market conditions and in line with the Group’s strategy to remain a long-term strategic holder of any subsidiaries.

(2) Back catalogue = games released in previous fiscal years
(3) CSR = Corporate Social Responsibility
(4) Live-ops = Extension of the game's commercial life after its launch via animations and micro-transactions.
(5) Nacon press release on 25 January 2021
(6) COI rate = Current Operating Income as a percentage of sales = Current Operating Margin

Next publication:

Q4 2020/21 sales: 26 April 2021
Press release after close of the Paris stock exchange



ABOUT BIGBEN INTERACTIVE



SALES 2019-2020
263.5 M€







HEADCOUNT
Ca. 750 employees



INTERNATIONAL
21 subsidiaries  and a distribution network in 100 countries
www.bigben-group.com


Bigben Interactive is a European player in video game development and publishing, in design and distribution of smartphone and gaming accessories as well as in audio products. The Group, which is recognized for its capacities in terms of innovation and creativity, intends to become one of Europe’s leaders in each of its markets



Company listed on Euronext Paris, compartment B – Index : CAC Mid & Small – Eligible SRD long
ISN : FR0000074072 ; Reuters : BIGPA ; Bloomberg : BIGFP



PRESS CONTACTS



CapValue – Gilles Broquelet gbroquelet@capvalue.fr - +33 1 80 81 50 01 

Attachment


About GlobeNewswire

GlobeNewswire
GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://globenewswire.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire

Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire

Remuneration of Directors by distribution of Millicom shares8.3.2021 16:50:27 CETPress release

Remuneration of Executives by distribution of Millicom shares Luxembourg, March 8, 2021 – Millicom International Cellular S.A. ("Millicom") announces that, in accordance with the vesting terms and conditions of its deferred share-based compensation plans, approved at Millicom’s 2018, 2019, and 2020 annual general meetings of shareholders, it has distributed treasury shares to eligible plan participants, including 42,833 shares to its executive management team. Details of the distributions are disclosed on Millicom’s website. -END- For further information, please contact: Press: Vivian Kobeh, Corporate Communications Director +1 786 628 5300 press@millicom.comInvestors: Michel Morin, VP Investor Relations +1 786 628 5270 investors@millicom.com Sarah Inmon, Investor Relations Senior Manager +1-786 628 5303 investors@millicom.com About Millicom Millicom (NASDAQ U.S.: TIGO, Nasdaq Stockholm: TIGO_SDB) is a leading provider of fixed and mobile services dedicated to emerging markets in Latin

Synchronoss Announces Appointment of Jeff Miller as Permanent CEO and President8.3.2021 15:21:20 CETPress release

BRIDGEWATER, N.J., March 08, 2021 (GLOBE NEWSWIRE) -- Synchronoss Technologies, Inc. (NASDAQ: SNCR), a global leader and innovator of cloud, messaging and digital solutions, today announced that its Board of Directors has confirmed Jeff Miller as its President and Chief Executive Officer. Miller had been serving as interim President and CEO of Synchronoss since September 2020 and joined Synchronoss in 2018 as Chief Commercial Officer. Prior to coming to Synchronoss, Miller was President of the Technology Group for IDEAL Industries, a firm focused on designing and delivering solutions for smart commercial buildings and spaces. He also served 16 years with Motorola, most recently as Corporate Vice President and General Manager of Operations in North America for Motorola Mobility, LLC, a division of Lenovo. Miller also held various leadership positions in sales management, marketing, and product management at AT&T during an 11-year tenure. “I have had the opportunity to work closely with

AMG Advanced Metallurgical Group N.V. Announces Long-Term Spent Catalyst Recycling Agreement8.3.2021 15:00:00 CETPress release

Amsterdam, 8 March 2021 --- AMG Advanced Metallurgical Group N.V. ("AMG", EURONEXT AMSTERDAM: "AMG") is pleased to announce that AMG Vanadium has signed a new long-term, multi-year agreement to process and recycle spent catalysts from a major oil refinery operator in North America. Located in Cambridge, Ohio, AMG Vanadium specializes in the environmentally beneficial conversion of oil refinery and power plant waste products into specialty metals used by global steel producers in automotive, energy transmission and infrastructure applications. By using materials that would otherwise be discarded as waste, AMG Vanadium facilitates environmental stewardship, energy conservation and resource recovery. About AMG AMG is a global critical materials company at the forefront of CO2 reduction trends. AMG produces highly engineered specialty metals and mineral products and provides related vacuum furnace systems and services to the transportation, infrastructure, energy, and specialty metals & ch

Nexstim Abp offentliggör EU-tillväxtprospekt avseende en företrädesemission på 6,6 miljoner euro8.3.2021 14:15:00 CETPressemelding

Företagsmeddelande, insiderinformation, Helsingfors den 8 mars 2021 kl. 15.15 (EET) Nexstim Abp offentliggör EU-tillväxtprospekt avseende en företrädesemission på 6,6 miljoner euro Nexstim Abp (NXTMH:HEX, NXTMS:STO) (”Nexstim” eller ”bolag”) meddelar med hänvisning till bolagets företagsmeddelande utgiven tidigare i dag, om en företrädesemission av cirka 6,6 miljoner euro att bolaget har upprättat ett EU-tillväxtprospekt som Finansinspektionen godkände den 8 mars 2021. Bolagets styrelse beslutade att offentliggöra EU-tillväxt prospektet den 8 mars 2021 och det ska notifieras till Sverige. EU-tillväxtprospektet på finska läggs omkring den 8 mars 2021 ut på Nexstims webbplats på www.nexstim.com/investors/rights-issue-2021 och tillhandahålls också på bolagets registrerade adress på Elimäkigatan 9 B, 00510 Helsingfors. Dessutom görs EU-tillväxtprospektet på finska tillgängligt på receptionen på Nasdaq Helsinki på Fabiansgatan 14, 00100 Helsingfors. EU-tillväxtprospektet på engelska och en

Nexstim Plc publishes an EU growth prospectus regarding EUR 6.6 million subscription rights issue8.3.2021 14:15:00 CETPress release

Company announcement, inside information, Helsinki, 8 March 2021 at 3.15 PM (EET) Nexstim Plc publishes an EU growth prospectus regarding EUR 6.6 million subscription rights issue Nexstim Plc (NXTMH:HEX, NXTMS:STO) (”Nexstim” or ”Company”) announces with reference to the company announcement published earlier today regarding a subscription rights issue totaling approximately EUR 6.6 million , that the Company has prepared an EU growth prospectus which the Finnish Financial Supervisory Authority (FIN-FSA) has approved on 8 March 2021. The Board of Directors of Nexstim has resolved to publish the EU growth prospectus on 8 March 2021 and it shall be notified to Sweden. Finnish version of the EU growth Prospectus will be available approximately on 8 March 2021 on the Nexstim’s website at http://www.nexstim.com/investors/rights-issue-2021 and at the registered office of the Company at Elimäenkatu 9 B, 00510 Helsinki. Moreover, the Finnish version of the EU growth prospectus will be availabl

Saniona får återkoppling från FDA gällande den regulatoriska vägen framåt för Tesomet mot hypotalamisk fetma8.3.2021 14:00:00 CETPressemelding

PRESSMEDDELANDE 8 mars 2021 Saniona (OMX: SANION), ett biofarmaceutiskt företag med klinisk utveckling fokuserad på sällsynta sjukdomar, meddelar idag att det amerikanska läkemedelsverket FDA lämnat återkoppling som ytterligare klarlägger det regulatoriska spåret för Tesomet som behandling av hypotalamisk fetma (HO). Baserat på den erhållna återkopplingen går Saniona vidare med planerna att inleda en fas 2b-studie på HO under första halvåret innevarande år. ”I dagsläget finns inga godkända mediciner för hypotalamisk fetma, en sällsynt sjukdom sekundär till skador i hypotalamus. Sjukdomen kännetecknas av svårhanterlig viktuppgång och kompliceras av okontrollerbar hunger”, säger Rudolf Baumgartner, Sanionas Chief Medical Officer och Head of Clinical Development. ”Återkopplingen från FDA är uppmuntrande, och vi ser fram emot att fortsätta den konstruktiva dialogen med myndigheten medan vi förbereder starten av vår kliniska fas 2b-studie med Tesomet.” Som Saniona tidigare meddelat har FDA

Saniona Receives Feedback from U.S. FDA Providing a Regulatory Path Forward for Tesomet in Hypothalamic Obesity8.3.2021 14:00:00 CETPress release

PRESS RELEASE March 8, 2021 Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced it received feedback from the U.S. Food and Drug Administration (FDA) providing further clarity on a regulatory path for Tesomet in the treatment of hypothalamic obesity (HO). Based on this feedback, Saniona is proceeding with plans to initiate a Phase 2b study in HO in the first half of this year. “There is currently no medicine approved for hypothalamic obesity, a rare disease secondary to hypothalamic injury, characterized by intractable weight gain and complicated by uncontrollable hunger,” said Rudolf Baumgartner, M.D., Chief Medical Officer and Head of Clinical Development at Saniona. “We are encouraged by this feedback from the FDA and look forward to continuing a constructive dialogue with them as we prepare to initiate our Phase 2b clinical trial with Tesomet.” Saniona previously announced that the FDA had highlighted the potential for off-lab